Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study.

Fumagalli S, Fattirolli F, Guarducci L, Cellai T, Baldasseroni S, Tarantini F, Di Bari M, Masotti G, Marchionni N.

Clin Cardiol. 2011 Apr;34(4):211-7. doi: 10.1002/clc.20846.

2.

Coenzyme q10 and creatine in heart failure: micronutrients, macrobenefit?

Ahmed M, Anderson SD, Schofield RS.

Clin Cardiol. 2011 Apr;34(4):196-7. doi: 10.1002/clc.20892. No abstract available.

3.

Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.

Hofman-Bang C, Rehnqvist N, Swedberg K, Wiklund I, Aström H.

J Card Fail. 1995 Mar;1(2):101-7.

PMID:
9420639
4.

The effect of coenzyme Q10 in patients with congestive heart failure.

Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R, Robinson SW, Gottlieb SS.

Ann Intern Med. 2000 Apr 18;132(8):636-40.

PMID:
10766682
5.

Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure.

Watson PS, Scalia GM, Galbraith A, Burstow DJ, Bett N, Aroney CN.

J Am Coll Cardiol. 1999 May;33(6):1549-52.

6.

Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction.

Udelson JE, DeAbate CA, Berk M, Neuberg G, Packer M, Vijay NK, Gorwitt J, Smith WB, Kukin ML, LeJemtel T, Levine TB, Konstam MA.

Am Heart J. 2000 Mar;139(3):503-10.

PMID:
10689266
8.

Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.

Lei L, Liu Y.

BMC Cardiovasc Disord. 2017 Jul 24;17(1):196. doi: 10.1186/s12872-017-0628-9.

9.

A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.

Northridge DB, Rose E, Raftery ED, Lahiri A, Elder AT, Shaw TR, Henderson E, Dargie HJ.

Eur Heart J. 1993 Mar;14(3):403-9.

PMID:
8458362
10.

Usefulness of taurine in chronic congestive heart failure and its prospective application.

Azuma J, Sawamura A, Awata N.

Jpn Circ J. 1992 Jan;56(1):95-9.

PMID:
1538580
11.

Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P.

J Am Coll Cardiol. 2008 Jan 15;51(2):103-12. doi: 10.1016/j.jacc.2007.09.036.

12.
13.

Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure.

Aquilani R, Viglio S, Iadarola P, Opasich C, Testa A, Dioguardi FS, Pasini E.

Am J Cardiol. 2008 Jun 2;101(11A):104E-110E. doi: 10.1016/j.amjcard.2008.03.008.

PMID:
18514618
14.

Effects of lisinopril in patients with heart failure and chronic atrial fibrillation.

Van Den Berg MP, Crijns HJ, Van Veldhuisen DJ, Griep N, De Kam PJ, Lie KI.

J Card Fail. 1995 Dec;1(5):355-63.

PMID:
12836710
15.

Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.

Lang RM, Elkayam U, Yellen LG, Krauss D, McKelvie RS, Vaughan DE, Ney DE, Makris L, Chang PI.

J Am Coll Cardiol. 1997 Oct;30(4):983-91.

16.

Effect of oral H2-receptor antagonists on left ventricular systolic function and exercise capacity in patients with chronic stable heart failure.

Lucas BD Jr, Williams MA, Mohiuddin SM, LaMadrid LJ, Schroeder LJ, Hilleman DE.

Pharmacotherapy. 1998 Jul-Aug;18(4):824-30.

PMID:
9692655
17.
18.

Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.

Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T, Bruns N, Fabian K, Tegenthoff M, Mortier W, Luttmann A, Zange J, Malin JP.

Arch Neurol. 2000 Jul;57(7):956-63.

PMID:
10891977
19.

Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure.

Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, Marino P, Zardini P.

J Am Coll Cardiol. 2002 Jul 17;40(2):304-10.

20.

Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.

Udelson JE, McGrew FA, Flores E, Ibrahim H, Katz S, Koshkarian G, O'Brien T, Kronenberg MW, Zimmer C, Orlandi C, Konstam MA.

J Am Coll Cardiol. 2007 Jun 5;49(22):2151-9. Epub 2007 May 18.

Supplemental Content

Support Center